104
Participants
Start Date
June 30, 2011
Primary Completion Date
February 28, 2013
MEGF0444A
Intravenous repeating dose
bevacizumab
Intravenous repeating dose
carboplatin
Intravenous repeating dose
paclitaxel
Intravenous repeating dose
placebo
Intravenous repeating dose
Budapest
Budapest
St Leonards
Tatabánya
Herston
Woodville South
Székesfehérvár
Albany
Marseille
Marseille
Hershey
Großhansdorf
Marietta
Toulouse
Orlando
Tampa
St. Petersburg
Port Saint Lucie
Birmingham
Nashville
Columbus
Saint-Herblain
Essen
Indianapolis
Burnsville
Lyon
Hot Springs
Le Mans
Paris
Fort Worth
Austin
Gauting
Las Vegas
Santa Monica
Portland
Vancouver
Wichita
Brno
Ostrava - Poruba
Halle
Bydgoszcz
Gdansk
Lead Sponsor
Genentech, Inc.
INDUSTRY